ASPI — ASP Isotopes Income Statement
0.000.00%
Last trade - 00:00- $382.68m
- $360.56m
- $4.14m
Annual income statement for ASP Isotopes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0 | 0.433 | 4.14 |
| Cost of Revenue | ||||
| Gross Profit | — | — | 0.139 | 1.6 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Total Operating Expenses | 2.61 | 5.1 | 16.5 | 30.5 |
| Operating Profit | -2.61 | -5.1 | -16 | -26.4 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -2.61 | -4.95 | -16.3 | -32.3 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -2.61 | -4.95 | -16.3 | -32.4 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Net Income | -2.61 | -4.95 | -16.3 | -32.3 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -2.61 | -4.95 | -16.3 | -35.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0.083 | -0.185 | -0.493 | -0.631 |
| Dividends per Share |